|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-2-26
|
|
pubmed:abstractText |
Co-expression of the epidermal growth factor receptor (EGFR) and of ErbB-2 is found in a subset of primary human breast cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AKT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/gefitinib,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-72
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11863114-Antibodies, Monoclonal,
pubmed-meshheading:11863114-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:11863114-Apoptosis,
pubmed-meshheading:11863114-Blotting, Western,
pubmed-meshheading:11863114-Breast Neoplasms,
pubmed-meshheading:11863114-Cell Division,
pubmed-meshheading:11863114-Cell Survival,
pubmed-meshheading:11863114-DNA, Neoplasm,
pubmed-meshheading:11863114-Dose-Response Relationship, Drug,
pubmed-meshheading:11863114-Drug Synergism,
pubmed-meshheading:11863114-Flow Cytometry,
pubmed-meshheading:11863114-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11863114-Humans,
pubmed-meshheading:11863114-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:11863114-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:11863114-Mitogen-Activated Protein Kinases,
pubmed-meshheading:11863114-Phosphorylation,
pubmed-meshheading:11863114-Protein-Serine-Threonine Kinases,
pubmed-meshheading:11863114-Proto-Oncogene Proteins,
pubmed-meshheading:11863114-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:11863114-Quinazolines,
pubmed-meshheading:11863114-Receptor, Epidermal Growth Factor,
pubmed-meshheading:11863114-Receptor, erbB-2,
pubmed-meshheading:11863114-Tumor Cells, Cultured
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.
|
|
pubmed:affiliation |
Oncologia Sperimentale D, Istituto Tumori Milano, Milan, Italy. nicnorm@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
